Cadrenal Therapeutics, Inc.
CVKD· Nasdaq
Released Mar 29, 2023, after the close
10-K filed Mar 30, 2023, 89 days after period end · 0001213900-23-024260
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
no prior Q4 2021 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cadrenal Therapeutics, Inc. · CIK 1937993 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 30, 2023 · 89 d after period end
+5.3% from the close of Mar 28, 2023 to the close of Mar 31, 2023, the first after the release.